Abstract:Background Rubella, commonly known as German measles, is caused by a single-stranded RNA genome. Vaccination is currently the most effective method for preventing rubella and its complications. Molecular docking, a computer-based technique used in drug discovery and development, is used to investigate the interactions between potential drug candidates and their target proteins. It predicts the binding interactions between small molecules (ligands) and the target protein. In this study, we examined a marine-derived drug from Rhizophora mucronata for its potential antiviral properties against the rubella capsid virus. Our objective was to identify the active inhibitory sites of the capsid virus. Materials and methods Protein and ligand molecules were retrieved from Protein Data Bank (PDB) and PubChem databases. The Lamarckian genetic algorithm was used to calculate molecular docking using Autodock Tools 1.5.7. The docking parameters used for each docked molecule were determined from 100 separate docking experiments with a maximum of 2.5×10-6 energy and a mutation rate of 2.0 and mass over ratio of 0.8. The results were recorded as docking parameter files (DPF). PyMOL was used to view and investigate the interactions between ligand fragments and rubella capsid protein. Results This approach plays a crucial role in the development of structure-based drugs. The results of the molecular docking suggest that Rhizophorin has the potential to bind with the rubella capsid protein. The strong binding affinity of -6.05 kcal/mol between the ligand and the protein further supports the potential of Rhizophorin as a therapeutic agent. The formation of hydrogen bonds between the ligand and amino acid residues Glu79, Arg82, and Thr118 indicates the significance of electrostatic interactions in the binding process. Furthermore, the hydrophobic interactions between the ligand and residues Ala81, Val84, Leu87, and Ile119 suggest the role of non-polar interactions in stabilizing the complex. The identified amino acid residues involved in these binding interactions could serve as potential targets for drug development. In future studies, experimental validation of the predicted interactions could provide further insights into the potential of Rhizophorin as an antiviral agent. Conclusion According to the findings of this study, the in silico investigation successfully identified a target for inhibiting the rubella virus (RuV) capsid receptor molecule. Future investigations on these compounds will require in vitro and in vivo studies using models that are more relevant to the medicinal potential of the capsid protein molecule.

Crystal structure and biochemical activity of the macrodomain from rubella virus p150

Crystal structure of the Rubella virus protease reveals a unique papain-like protease fold

The Capsid Protein of Rubella Virus Antagonizes RNA Interference in Mammalian Cells

Identifying novel chemical matter against the Chikungunya virus nsP3 macrodomain through crystallographic fragment screening

Computational Analysis of a Marine-Derived Drug From Rhizophora mucronata Against the Capsid Protein of Rubella Virus

Long non-coding RNAs — regulators of rubella virus infection and antiviral response

A single-point mutation in the rubella virus E1 glycoprotein promotes rescue of recombinant vesicular stomatitis virus

Viral Macro Domains Reverse Protein ADP-Ribosylation

Crystal Structures Of Two Coronavirus Adp-Ribose-1 ''-Monophosphatases And Their Complexes With Adp-Ribose: A Systematic Structural Analysis Of The Viral Adrp Domain

Rubella virus assembly requirements and evolutionary relationships with novel rubiviruses

Structural, Biophysical, and Biochemical Elucidation of the SARS-CoV-2 Nonstructural Protein 3 Macro Domain

Evolutionary and molecular basis of ADP-ribosylation reversal by zinc-dependent macrodomains

The SARS-CoV-2 Conserved Macrodomain Is a Mono-ADP-Ribosylhydrolase

S phingomyelin synthase 1 supports two steps of rubella virus life cycle

Exploring the mechanism how Marburg virus VP35 recognizes and binds dsRNA by molecular dynamics simulations and free energy calculations

Structural analysis of monomeric retroviral reverse transcriptase in complex with an RNA/DNA hybrid

Structural insights into RNA recognition by the Chikungunya virus nsP2 helicase

Extensive exploration of structure activity relationships for the SARS-CoV-2 macrodomain from shape-based fragment merging and active learning

Pyrimidone Inhibitors Targeting Chikungunya Virus Nsp3 Macrodomain by Fragment-Based Drug Design

Structural and Functional Studies of Chikungunya Virus nsP2